Archives
The Beers Criteria was updated in 2019. Of the numerous updates, I wanted to pull out my top 5 clinically relevant Beers Criteria updates. It is important to note that there were many more updates, but I wanted to share some of the most clinically important updates. Discussed in the video are Beers Criteria updates […]
Read More
Benzodiazepines are on the Beers criteria. They can have significant adverse effects like sedation, confusion, the risk for dependence, and increased fall risk. We like to avoid benzodiazepines if we can, but what if we do feel that it is necessary (i.e. hospice or other situation)? I have been asked this question before and will […]
Read More
Parkinson’s is one of the most complex disease states you will encounter. Whenever you talk about a disease of the brain and nervous system, you know that we likely don’t have a 100% clear understanding of how it works and why it happens. However, we definitely know that dopamine plays a critical role in these […]
Read MoreOrthostasis risk with SGLT-2 Inhibitors is a potential minor concern, particularly in our geriatric population. While a drop in blood pressure can be a good thing for a significant chunk of diabetes patients, that potential modest drop can lead to an increased risk of adverse effects as well. Here’s the case of assessing orthostasis risk […]
Read More
It is really hard to narrow down a list of thousands of drugs to 5. Right or wrong, I did it. I based my subjective list upon frequency of use, highest risk for medication errors, significance when an error occurs, drug interactions, and risk of hospitalization. Here is my list of the Top 5 High Risk Medications […]
Read More